91 related articles for article (PubMed ID: 18782615)
1. Response surface methodology in the optimization of chitosan-Ca pectinate bead formulations.
Mennini N; Furlanetto S; Maestrelli F; Pinzauti S; Mura P
Eur J Pharm Sci; 2008 Nov; 35(4):318-25. PubMed ID: 18782615
[TBL] [Abstract][Full Text] [Related]
2. Gamma-oryzanol-loaded calcium pectinate microparticles reinforced with chitosan: optimization and release characteristics.
Lee JS; Kim JS; Lee HG
Colloids Surf B Biointerfaces; 2009 May; 70(2):213-7. PubMed ID: 19171467
[TBL] [Abstract][Full Text] [Related]
3. Influence of cross-linking agent type and chitosan content on the performance of pectinate-chitosan beads aimed for colon-specific drug delivery.
Maestrelli F; Cirri M; Mennini N; Bragagni M; Zerrouk N; Mura P
Drug Dev Ind Pharm; 2012 Sep; 38(9):1142-51. PubMed ID: 22191551
[TBL] [Abstract][Full Text] [Related]
4. Zinc-pectinate beads as an in vivo self-assembling system for pulsatile drug delivery.
Dhalleine C; Assifaoui A; Moulari B; Pellequer Y; Cayot P; Lamprecht A; Chambin O
Int J Pharm; 2011 Jul; 414(1-2):28-34. PubMed ID: 21601627
[TBL] [Abstract][Full Text] [Related]
5. Colon-Targeted Delivery of IgY Against Clostridium difficile Toxin A and B by Encapsulation in Chitosan-Ca Pectinate Microbeads.
Xing P; Shi Y; Dong C; Liu H; Cheng Y; Sun J; Li D; Li M; Sun K; Feng D
AAPS PharmSciTech; 2017 May; 18(4):1095-1103. PubMed ID: 27826799
[TBL] [Abstract][Full Text] [Related]
6. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone.
Wittaya-areekul S; Kruenate J; Prahsarn C
Int J Pharm; 2006 Apr; 312(1-2):113-8. PubMed ID: 16490331
[TBL] [Abstract][Full Text] [Related]
7. Development of enteric-coated calcium pectinate microspheres intended for colonic drug delivery.
Maestrelli F; Cirri M; Corti G; Mennini N; Mura P
Eur J Pharm Biopharm; 2008 Jun; 69(2):508-18. PubMed ID: 18194852
[TBL] [Abstract][Full Text] [Related]
8. Colon-specific delivery of resveratrol: optimization of multi-particulate calcium-pectinate carrier.
Das S; Ng KY
Int J Pharm; 2010 Jan; 385(1-2):20-8. PubMed ID: 19833179
[TBL] [Abstract][Full Text] [Related]
9. Drug release property of chitosan-pectinate beads and its changes under the influence of microwave.
Wong TW; Nurjaya S
Eur J Pharm Biopharm; 2008 May; 69(1):176-88. PubMed ID: 17980563
[TBL] [Abstract][Full Text] [Related]
10. Formulation optimization of chelerythrine loaded O-carboxymethylchitosan microspheres using response surface methodology.
Li GY; Zhong M; Zhou ZD; Zhong YD; Ding P; Huang Y
Int J Biol Macromol; 2011 Dec; 49(5):970-8. PubMed ID: 21889529
[TBL] [Abstract][Full Text] [Related]
11. Influence of polymers weight ratio and pH of polymers solution on the characteristics of chitosan-carboxymethyl cellulose microspheres containing theophylline.
Bayomi MA
Boll Chim Farm; 2003 Oct; 142(8):336-42. PubMed ID: 15040463
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol-loaded calcium-pectinate beads: effects of formulation parameters on drug release and bead characteristics.
Das S; Ng KY
J Pharm Sci; 2010 Feb; 99(2):840-60. PubMed ID: 19653272
[TBL] [Abstract][Full Text] [Related]
13. Pectin and charge modified pectin hydrogel beads as a colon-targeted drug delivery carrier.
Jung J; Arnold RD; Wicker L
Colloids Surf B Biointerfaces; 2013 Apr; 104():116-21. PubMed ID: 23298595
[TBL] [Abstract][Full Text] [Related]
14. Encapsulation of Lactobacillus casei into Calcium Pectinate-Chitosan Beads for Enteric Delivery.
Bepeyeva A; de Barros JMS; Albadran H; Kakimov AK; Kakimova ZK; Charalampopoulos D; Khutoryanskiy VV
J Food Sci; 2017 Dec; 82(12):2954-2959. PubMed ID: 29125623
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of critical formulation parameters influencing the bioactivity of beta-lactamases entrapped in pectin beads.
Bourgeois S; Gernet M; Pradeau D; Andremont A; Fattal E
Int J Pharm; 2006 Oct; 324(1):2-9. PubMed ID: 16822628
[TBL] [Abstract][Full Text] [Related]
16. Spray drying formulation of albendazole microspheres by experimental design. In vitro-in vivo studies.
García A; Leonardi D; Piccirilli GN; Mamprin ME; Olivieri AC; Lamas MC
Drug Dev Ind Pharm; 2015 Feb; 41(2):244-52. PubMed ID: 24237328
[TBL] [Abstract][Full Text] [Related]
17. Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-β-cyclodextrin-PVP complex.
Mennini N; Furlanetto S; Cirri M; Mura P
Eur J Pharm Biopharm; 2012 Jan; 80(1):67-75. PubMed ID: 21864681
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in vitro evaluation of chitosan microspheres containing prednisolone: comparison of simple and conjugate microspheres.
Onishi H; Oosegi T; Machida Y; McGinity JW
Drug Dev Ind Pharm; 2005 Aug; 31(7):597-605. PubMed ID: 16207606
[TBL] [Abstract][Full Text] [Related]
19. Pectin/chitosan/Eudragit RS mixed-film coating for bimodal drug delivery from theophylline pellets: preparation and evaluation.
Ghaffari A; Oskoui M; Helali K; Bayati K; Rafiee-Tehrani M
Acta Pharm; 2006 Sep; 56(3):299-310. PubMed ID: 19831279
[TBL] [Abstract][Full Text] [Related]
20. Formulation and characterization of a compacted multiparticulate system for modified release of water-soluble drugs--Part II theophylline and cimetidine.
Cantor SL; Hoag SW; Augsburger LL
Drug Dev Ind Pharm; 2009 May; 35(5):568-82. PubMed ID: 18979306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
